Share the Tech If mRNA vaccine technology from Moderna, BioNTech and Pfizer were shared, manufacturers in low- and middle-income countries could produce vaccines for global pandemic preparedness, as well as diseases of concern such as HIV, TB and malaria.
Shailly Gupta @MSF_access requested the chief negotiators of 16 countries at #RCEP stakeholders consultation to take into consideration that Intelectual property negotiations will have a global impact on the sustainable supply of quality assured generic medicines 21:53 - 22 Jul 2018